Tacrolimus Impurity 10 | CAS 157141-17-8 - Request Quote
Tacrolimus Impurity 10
| SZ CAT No: | SZ-T005048 |
| CAS No | 157141-17-8 |
| Mol.F. | C42H65NO12 |
| Mol.Wt. | 776.0 |
| Inv. Status | Synthesis on demand |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tacrolimus Impurity 10 is chemically . Tacrolimus Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Tacrolimus Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tacrolimus.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 157141-17-8
Purchase 157141-17-8
Order 157141-17-8
Enquire 157141-17-8
price of 157141-17-8
157141-17-8 Supplier
157141-17-8 Manufacturer
157141-17-8 Exporter
buy high quality Tacrolimus Impurity 10
Purchase Tacrolimus Impurity 10
Tacrolimus Impurity 10 suppliers
Tacrolimus Impurity 10 manufacturers
Tacrolimus Impurity 10 price
Order Tacrolimus Impurity 10
Enquire Tacrolimus Impurity 10
Tacrolimus Impurity 10 cost
Tacrolimus Impurity 10 Supplier
Tacrolimus Impurity 10 Distributor
Tacrolimus Impurity 10 for Method Validation
Tacrolimus Reference Standard
Tacrolimus Impurity 10 for ANDA Filing
Tacrolimus Impurity 10 for Forced Degradation Studies
Tacrolimus Impurity 10 Identification Standards
Tacrolimus Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


